Τετάρτη 25 Νοεμβρίου 2020

A laboratory study to assess the formation of effluent volatile compounds and disinfection by‐products during chemomechanical preparation of infected root canals and application of activated carbon for their removal

a.lsfakia shared this article with you from Inoreader

ABSTRACT

Aim

To assess in a laboratory setting using extracted teeth the formation of volatile compounds (VOCs) and disinfection by‐products (DBPs) in effluent aliquots, during chemomechanical preparation of artificially infected root canal specimens, and determine the role of silver‐impregnated activated carbon (Ag‐AC) in their removal.

Methodology

Single‐rooted human teeth were decoronated to obtain 15mm‐long root specimens and a nutrient‐stressed multispecies biofilm was grown in the root canals. Specimens were randomly assigned into three groups [Group 1; instrumentation with rotary files and irrigation with sterile saline, Groups 2 and 3; instrumentation with rotary files and irrigation with 2.5% NaOCl and 17% EDTA]. A portable medical suction device was used to collect the effluent aliquots during root canal irrigation. In Groups 1 and 2, the reaction products of the collected effluents were analysed by selected ion flow tube mass spectrometry (SIFT‐MS). The effluents from Group 3 were treated with Ag‐AC prior to SIFT‐MS analysis, to assess the removal capacity of Ag‐AC against the reaction products. The synthesis of Ag‐AC was characterised with scanning electron microscopy/energy dispersive X‐ray spectroscopy (SEM/EDS). Two‐way analysis of variance (ANOVA) with post hoc Tukey tests were used for dat a analysis and determination of a significant difference (P<0.05).

Results

In Group 1, effluent VOCs and DBPs were detectable at very low levels. In Group 2, the collected effluent aliquots released high concentrations of methanol, propanol, ammonia, chloroform and formaldehyde, which were significantly greater compared to Group 1 (P<0.001). SEM/EDS analysis confirmed impregnation of Ag within the AC matrix. The treatment of effluent aliquots with Ag‐AC (Group 3) resulted in a significant reduction in concentrations of acetone, acetic acid, propanol, acetaldehyde, acetonitrile and chloroform, compared to Group 2 (P<0.001). The concentration levels of ethanol, methanol, ammonia and formaldehyde remained unaffected (P>0.05).

Conclusions

In this laboratory setting using extracted human teeth, the chemomechanical preparation of artificially infected root canals resulted in the formation of toxic volatile compounds and disinfection by‐products as effluent suspensions. Their release during aspiration with dental suction indicates that potential environmental hazards should be investigated. The use of silver‐impregnated activated carbon had potential for the point‐of‐use treatment of post‐irrigation effluent aliquots.

View on the web

Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells

o.lakala70 shared this article with you from Inoreader
Publication date: Available online 25 November 2020Source: Chemico-Biological InteractionsAuthor(s): Marina Petrenko, Antje Güttler, Anne Funtan, Jacqueline Keßler, Daniel Emmerich, Reinhard Paschke, Dirk Vordermark, Matthias Bache (Source: Chemico Biological Interactions)
View on the web

MicroRNA-188-5p targeting Forkhead Box L1 promotes colorectal cancer progression via activating Wnt/ β-catenin signaling.

o.lakala70 shared this article with you from Inoreader
This study aimed to explore its role in colorectal cancer (CRC). Human CRC tissues paired with normal tissues, and several CRC cell lines were utilized. Real-time quantitative PCR was applied to measure the expression of miR-188. Overexpression and knockdown were used to access the function of miR-188 and to investigate whether FOXL1/Wnt signaling mediates such function. The proliferation, migration and invasion of cancer cells were evaluated by CCK8, wound-healing and transwell assays, respectively. Whether FOXL1 acted as a direct target of miR-188 was verified by dual-luciferase reporter assays. Levels of miR-188 were upregulated in CRC tissues than in paired-normal tissues, as well as in various CRC cell lines. High expression of miR-188 was strongly associated with advanced tumor stage...
View on the web

Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience.

o.lakala70 shared this article with you from Inoreader
CONCLUSION: Erlotinib-associated GT was identified in 15% patients with NSCLC. Fluid-filled colon and segmental involvement were the most common imaging manifestations. PMID: 32892106 [PubMed - indexed for MEDLINE] (Source: Clinical Lung Cancer)
View on the web

Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers.

o.lakala70 shared this article with you from Inoreader
CONCLUSION: Based on these results, clinical Stage IA for non-small-cell-lung-cancers with nonsolid, part-solid, or solid consistency should be based on pre-surgical CT maximum tumor diameter and lymph node short-axis measurements on CT ≤20 mm. Further prospective evaluation of these clinical Stage IA staging criteria is needed. PMID: 32570011 [PubMed - indexed for MEDLINE] (Source: Clinical Lung Cancer)
View on the web

The expression and function of immunoglobulin-like transcript 4 in dendritic cells from patients with hepatocellular carcinoma.

o.lakala70 shared this article with you from Inoreader
Authors: Fan J, Han J, Li J, Gu A, Yin D, Song F, Wang L, Yi Y Abstract Due to their easy availability and expansion in vitro, monocyte-derived dendritic cells (moDCs) are most frequently used for tumor vaccination. Immunoglobulin-like transcript 4 (ILT4), as inhibitory receptor, has been reported to be related to DC tolerance. However, the influence of ILT4 for DC tolerance in hepatocellular carcinoma (HCC) patients has not been illustrated. In this research, we explored the expression of ILT4 on moDCs from HCC patients and its effect on moDC function. We demonstrated that the expression of ILT4 on mature DCs (mDCs) was higher in the peripheral blood from HCC patients than in that from healthy donors. The levels of cytokines IL-1β and IL-6 secreted by mDCs from both HCC patients ...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

View on the web

Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients

Cancer shared this article with you from Inoreader

12885.jpg

Abstract

Background

Allogeneic stem cell transplantation from haploidentical donor using an unmanipulated graft and post-transplantation cyclophosphamide (PT-Cy) is growing. Haploidentical transplantation with PT-Cy showed a major activity in Hodgkin lymphoma (HL), reducing the relapse incidence. The most important predictive factor of survival and toxicity was disease status before transplantation, which was better in patients with well controlled disease.

Methods

We included 198 HL in complete (CR) or partial remission (PR) before transplantation. Sixty-five patients were transplanted from haploidentical donor and 133 from a HLA identical donor (both sibling and unrelated donors). Survival analysis was defined according to the EBMT criteria. Survival curves were generated by using Kaplan-Meier method and differences between groups were compared by the log rank test or by the log rank test for trend when appropriated.

Results

The PFS, OS, and RI were significantly better in patients in CR compared to PR (55% vs 29% p = 0.001, 74% vs 55% p = 0.03, 27% vs 55% p <  0.001, respectively). The 2-year PFS was significantly better for HAPLO than HLA-id (63% vs 37%, p = 0.03), without difference in OS. The 1-year NRM was not different. The 2-year relapse incidence (RI) was lower in the HAPLO group (24% vs 44%, p = 0.008). Patients in CR receiving haplo HSCT showed higher 2-year PFS and lower 2-year RI than those allografted with HLA-id donor (75% vs 47%, p <  0.001 and 11% vs 34%, p < 0.001, respectively). In multivariate analysis, donor type and disease status before transplantation were independent predictors of PFS as well as they predict the risk of relapse. Disease status at transplantation and age were independently associated to OS.

Conclusions

Nonetheless this is a retrospective study, limiting the wide applicability of results, data from this analysis suggest that HLA mismatch can induce a strong graft versus lymphoma effect leading to an enhanced PFS.

View on the web

Physical activity and exercise in cancer patients with bone metastases

Cancer shared this article with you from Inoreader

12254.jpg

Summary

Physical activity and exercise can have numerous positive effects on various disease- and therapy-related symptoms across the continuum of cancer disease. These include an improvement in quality of life, physical function, aerobic fitness, muscle strength and muscle mass, bone density and a reduction of insomnia, psychological distress, pain and fatigue. Although no higher fracture incidence could be found in several studies, exercise is still often considered contraindicated in patients with bone metastases due to concerns about skeletal-related events such as pathologic fractures, spinal cord compression, aggravating pain, increased mortality and higher health care costs. This short, narrative review reports general considerations about physical activity in patients with cancer. In particular, it focuses on principles, precautions and contraindications regarding exercise recommendations for patients with metastatic bone disease in order to implem ent safe and efficient exercise interventions.

View on the web

Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway

Cancer shared this article with you from Inoreader

41417_2020_238_Fig1_HTML.png

View on the web

A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma

Cancer shared this article with you from Inoreader

1-s2.0-S0360301620X00319-cov150h.gif

Publication date: Available online 23 November 2020

Source: International Journal of Radiation Oncology*Biology*Physics

Author(s): Kevin X. Liu, Myrsini Ioakeim-Ioannidou, Matthew S. Susko, Avani D. Rao, Beow Y. Yeap, Antoine M. Snijders, Matthew M. Ladra, Jennifer Vogel, Cierra Zaslowe-Dude, Karen J. Marcus, Torunn I. Yock, Clemens Grassberger, Steve E. Braunstein, Daphne A. Haas-Kogan, Stephanie A. Terezakis, Shannon M. MacDonald

View on the web

Feasibility and safety of exercise training and nutritional support prior to haematopoietic stem cell transplantation in patients with haematologic malignancies

Cancer shared this article with you from Inoreader

12885.jpg

Abstract

Background

Prehabilitation with regular exercise and nutritional care for patients undergoing surgeries for malignant disease was recently introduced to increase physiologic reserve prior to the procedure, accelerate recovery and improve outcomes. This study aimed to investigate the feasibility and safety of combined exercise training and nutritional support in patients with haematologic malignancies prior to haematopoietic stem cell transplantation (HSCT).

Methods

In this single-arm pilot study, 34 HSCT candidates were enrolled at least two weeks before admission for the procedure. Patients performed aerobic exercises at least 4 days per week for 20–30 min and strength exercises 3 days per week for 10–20 min. They received daily supplements of whey protein (0.3–0.4 g/kg body weight) and oral nutritional supplements if needed. The primary endpoints were feasibility (acceptability > 75%, attrition < 20%, adherence > 66%) and safety. The secondary endpoints were fat-free mass (FFM), muscle strength, physical performance and health-related quality of life (HRQoL) at HSCT.

Results

The rate of acceptability, attrition and adherence to aerobic exercise, strength exercise and protein supplement consumption was 82.4, 17.8, 71, 78 and 80%, respectively. No severe adverse events were reported. Twenty-eight patients participated in the study for a median of 6.0 weeks (range, 2–14). They performed aerobic exercises 4.5 days per week for 132 min per week and strength exercises 3.0 times per week. Patients consumed 20.7 g of extra protein daily. At the end of the programme, we recorded increases of 1.1 kg in FFM (p = 0.011), 50 m in walking distance in the 6-min walking test (6MWT) (p < 0.001), 3.3 repetitions in the 30-s chair-stand test (30sCST) score (p < 0.001) and 2.6 kg in handgrip strength (p = 0.006). The EORTC QLQ-C30 scores improved by 8.6 (p < 0.006) for global health status, 8.3 (p = 0.009) for emotional functioning, and 12.1 (p =  0.014) for social functioning. There was less fatigue, nausea and insomnia (p < 0.05).

Conclusions

Our study shows that a multimodal intervention programme with partially supervised exercise training combined with nutritional support prior to HSCT is feasible and safe. Patients showed improvements in FFM, physical performance and HRQoL. Additional research is needed to assess the possible positive effects of such interventions.

View on the web

Eradication of T-ALL cells by CD7 targeted universal CAR-T cells and initial test of ruxolitinib-based CRS management

Cancer shared this article with you from Inoreader

Purpose:Although chimeric antigen receptor T cell (CAR-T) therapy development for B cell malignancies has made significant progress in the last decade, broadening the success to treating T-ALL has been limited. We conducted two clinical trials to verify the safety and efficacy of GC027, an "off-the-shelf" allogeneic CAR-T product targeting T cell antigen CD7. Here we report two patients as case reports with relapsed/refractory T-ALL who were treated with GC027. Experimental Design:Both of the two trials reported are open-labeled and single-arm. A single infusion of GC027 was given to each patient after preconditioning therapy. Result:Robust expansion of CAR-T cells along with rapid eradication of CD7+ T-lymphoblasts were observed in the peripheral blood, bone marrow and cerebrospinal fluid. Both patients achieved complete remission (CR) with no minimal residual disease (MRD) detectable. At data cut off Sep.30, 2020 one of the two patients remains in ongoing remission for over one year after CAR-T cell infusion. Grade 3 cytokine release syndrome (CRS) occurred in both patients and was managed by a novel approach with a ruxolitinib-based CRS management. Ruxolitinib showed promising activity in a preclinical study conducted at our center. No Graft-versus-host-disease (GvHD) was observed. Conclusion:The two case reports demonstrate that a stand alone therapy with this novel CD7 targeted "off-the-shelf" allogeneic CAR-T therapy may provide deep and durable responses in select r/r T-ALL patients. GC027- might have a potential to be a promising new approach for treating refractory/relapsed T - ALL. Further studies are warranted.

View on the web

Αρχειοθήκη ιστολογίου